Yahoo Finance

Successful Completion of In-Vivo Head-to-Head Comparator Study of EscharEx versus a Commercial Enzymatic Debridement Agent

YAVNE, Israel, Dec. 21, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and ...
Yahoo Finance

MediWound Announces Peer-Reviewed Publication of EscharEx In-Vivo Head-to-Head Comparator Study in the Journal of Wound Care

YAVNE, Israel, Oct. 04, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and ...
Healio

Botanical drug may outperform standard of care for treatment of severe thermal burns

Please provide your email address to receive an email when new articles are posted on . Phase 3 data shows NexoBrid allows for the early complete eschar removal in more than 90% of patients. This ...
McKnight's Long-Term Care News

Ask the Treatment Expert about … eschar

When eschar is present, what are the best practices for treating pressure injuries that occur on the heel? Approximately one-quarter of all pressure injuries (ulcers) are located on the heel. Pressure ...
Monthly Prescribing Reference

FDA Issues Complete Response Letter for Burn Therapy NexoBrid

NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes. The Food and Drug Administration (FDA) has issued a Complete Response ...
Nasdaq

MediWound Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

YAVNE, Israel, Sept. 16, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “MediWound”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in ...
Stockhouse

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Results demonstrate superiority of EscharEx®, a bromelain-based gel vs. SANTYL®, a collagenase ointment, in wound debridement, promotion of granulation tissue, and time to wound ...
The New England Journal of Medicine

Acid Débridement of Burns with Phosphoric-Acid Gel

THE introduction of a satisfactory chemical method for the early débridement of burns would simplify a perplexing problem. For many years attempts have been made to find some agent that would ...
Business Insider

Vericel Enters into Exclusive License Agreement with MediWound for North American Rights to NexoBrid, a Biological Orphan Product for Debridement of Severe Thermal Burns

Pivotal U.S. Phase 3 Clinical Study Met Primary and All Secondary Endpoints Highly Synergistic with Existing Commercial Franchise and Significantly Expands Vericel’s Presence in the Severe Burn Care ...
Medscape

What’s Your Assessment?

The patient had marked pitting edema in the right lower leg. Early scarring was present on the knee, right medial leg, and right medial malleolus at the sites of rod and screw insertion. On the ...